Market Research Logo

Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)

Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)

The global latent tuberculosis infection (LTBI) testing market is estimated to reach US$2.1 billion in 2023, growing at a CAGR of 5.59% for the period spanning from 2018 to 2023. The factors such as rapid tuberculosis prevalence, increased tuberculosis awareness, rising prevalence of HIV and increasing government initiatives are expected to drive the market growth. However, growth of the industry will be challenged by multidrug resistant tuberculosis, lack of laboratory facilities and lack of awareness in emerging markets. A few notable trends include increasing government initiatives, increasing healthcare expenditure in emerging countries and advanced and hybrid technologies.

The latent tuberculosis infection testing market comprises two main segments namely Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). TST being a traditional test for tuberculosis diagnosis is the most recommended test. In the global latent tuberculosis testing market, the tuberculin skin test segment accounted for the higher share in 2018.

The fastest growing regional market is the U.S. due to increasing public awareness and increasing healthcare expenditure on diagnosis and treatment in developing countries. The U.S. represents one of the largest market for LTBI testing and is already well-penetrated at developed market levels. China, Japan and Europe and Middle East are emerging markets where growth lies in government expenditure on disease related initiatives and technological developments.

Scope of the report:

  • The report provides a comprehensive analysis of the global latent tuberculosis infection (LTBI) testing market, segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA) segments.
  • The major regional markets (Europe and Middle East, Asia Pacific (Excluding Japan and China) and Latin America) have been analyzed, along with country coverage of US, China and Japan.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Qiagen, Abbott, Becton Dickinson, Biomerieux, Roche and Thermo Fisher Scientific) are also presented in detail.
Key Target Audience:
  • Latent Tuberculosis Infection (LTBI) Testing Devices Manufacturers
  • Raw Material/Component Suppliers
  • End Users (Physician Offices, Hospitals, Healthcare Clinics)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities


1. Market Overview 18
1.1 Tuberculosis (TB)
Table 1: Symptoms of TB
1.2 Types of Tuberculosis (TB)
Table 2: Types of TB
1.3 Latent Tuberculosis Infection (LTBI)
Table 3: Differences between Latent TB and Active TB
1.4 Risk Factors of Latent Tuberculosis
Table 4: Risk Factors of Latent Tuberculosis
1.5 Types of Latent Tuberculosis Infection Testing
Table 5: Types of Latent Tuberculosis Infection Testing
1.6 Latent Tuberculosis Infection Testing Segmentation
Table 6: Latent Tuberculosis Infection Testing Segmentation
2. Global LTBI Testing Market
2.1 Global LTBI Testing Market Forecast by Value
Table 7: Global LTBI Testing Market Forecast by Value (2018-2023)
2.2 Global LTBI Testing Market Value by Region
Table 8: Global LTBI Testing Market Value by Region (2018)
2.3 Global LTBI Testing Market Forecast by Volume
Table 9: Global LTBI Testing Market Forecast by Volume (2018-2023)
2.4 Global LTBI Testing Market Volume by Region
Table 10: Global LTBI Testing Market Volume by Region (2018)
2.5 Global LTBI Testing Market Volume by Segment
Table 11: Global LTBI Testing Market Volume by Segments (2018)
2.5.1 Global IGRA Testing Market Forecast by Volume
Table 12: Global IGRA Test Market Forecast by Volume (2018-2023)
2.5.2 Global TST Market Forecast by Volume
Table 13: Global TST Market Forecast by Volume (2018-2023)
3. Regional LTBI Testing Market
3.1 The U.S.
3.1.1 The U.S. LTBI Testing Market Forecast by Value
Table 14: The U.S. LTBI Testing Market Forecast by Value (2018-2023)
3.1.2 The U.S. LTBI Testing Market Forecast by Volume
Table 15: The U.S. LTBI Testing Market Forecast by Volume (2018-2023)
3.1.3 The U.S. LTBI Testing Market by End User
Table 16: The US LTBI Testing Market by End User (2018)
3.2 China
3.2.1 China LTBI Testing Market Forecast by Value
Table 17: China LTBI Testing Market Forecast by Value (2018-2023)
3.2.2 China LTBI Testing Market Forecast by Volume
Table 18: China LTBI Testing Market Forecast by Volume (2018-2023)
3.3 Asia-Pacific (Excluding Japan and China)
3.3.1 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value
Table 19: Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value (2018-2023)
3.3.2 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume
Table 20: Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume (2018-2023)
3.4 Latin America
3.4.1 Latin America LTBI Testing Market Forecast by Value
Table 21: Latin America LTBI Testing Market Forecast by Value (2018-2023)
3.4.2 Latin America LTBI Testing Market Forecast by Volume
Table 22: Latin America LTBI Testing Market Forecast by Volume (2018-2023)
3.5 Japan
3.5.1 Japan LTBI Testing Market Forecast by Value
Table 23: Japan LTBI Testing Market Forecast by Value (2018-2023)
3.5.2 Japan LTBI Testing Market Forecast by Volume
Table 24: Japan LTBI Testing Market Forecast by Volume (2018-2023)
3.6 Europe and Middle East
3.6.1 Europe and Middle East LTBI Testing Market Forecast by Value
Table 25: Europe and Middle East LTBI Testing Market Forecast by Value (2018-2023)
3.6.2 Europe and Middle East LTBI Testing Market Forecast by Volume
Table 26: Europe and Middle East Mark LTBI Testing Market Forecast by Volume (2018-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Awareness of Tuberculosis
Table 27: Global Literacy Rate (2014-2018)
4.1.2 Rising Geriatric Population
Table 28: Global Geriatric Population (2014-2018)
4.1.3 Declining Tobacco Price
Table 29: Global Tobacco Price (2013-2021)
4.1.4 Increasing Tuberculosis Detection Rate
Table 30: Global Tuberculosis Case Detection Rate (2014-2018)
4.1.5 Upsurge in Cigarette Consumption
Table 31: Global Cigarette Consumption (2014-2020)
4.1.6 Growing Urban Population
Table 32: Global Urban Population (2014-2019)
4.1.7 Rising Prevalence of HIV
Table 33: Global HIV Population (2014-2018)
4.2 Key Trends & Developments
4.2.1 Increasing Government Initiatives
4.2.2 Increasing Healthcare Expenditure in Emerging Markets
Table 34: Global Healthcare Expenditure (1995-2022)
4.2.3 Expansion of Advanced and Hybrid Technique
4.2.4 Line Probe Assays (LPAs)
Table 35: Current LPA products and Associated Equipment
4.2.5 Nucleic Acid Amplification Tests (NAATs)
Table 36: NAAT-based Technologies
4.3 Challenges
4.3.1 Stringent Government Regulations
4.3.2 Multidrug Resistant Tuberculosis (MDR-TB)
4.3.3 Lack of Awareness in Emerging market
4.3.4 Lack of Laboratory Facilities
5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
Table 37: Revenue Comparison of Key Players (2018)
5.1.2 Market Cap Comparison of Key Players
Table 38: Market Cap Comparison of Key Players (2018)
5.1.3 R&D Comparison of Key Players
Table 39: R&D Comparison of Key Players (2017-2018)
6. Company Profiles
6.1 Qiagen
6.1.1 Business Overview
6.1.2 Financial Overview
Table 40: Qiagen Net Sales and Net Income (2014-2018)
Table 41: Qiagen Net Sales by Segment (2018)
Table 42: Qiagen Net Sales by Region (2018)
6.1.3 Business Strategies
6.2 Abbott
6.2.1 Business Overview
6.2.2 Financial Overview
Table 43: Abbott Net Sales and Net Earnings (2014-2018)
Table 44: Abbott Net Sales by Segment (2018)
Table 45: Abbott Net Sales by Region (2018)
6.2.3 Business Strategies
6.3 Becton Dickinson
6.3.1 Business Overview
6.3.2 Financial Overview
Table 46: Becton Dickinson Revenue and Net Income (2014-2018)
Table 47: Becton Dickinson Revenue by Segment (2018)
Table 48: Becton Dickinson Revenue by Region (2018)
6.3.3 Business Strategies
6.4 BioMerieux
6.4.1 Business Overview
6.4.2 Financial Overview
Table 49: BioMerieux Sales and Net Income (2014-2018)
Table 50: BioMerieux Sales by Segment (2018)
Table 51: BioMerieux Sales by Region (2018)
6.4.3 Business Strategies
6.5 Roche Holding AG
6.5.1 Business Overview
6.5.2 Financial Overview
Table 52: Roche Holding AG Revenue and Net Income (2014-2018)
Table 53: Roche Holding AG Revenue by Segment (2018)
Table 54: Roche Holding AG Revenue by Region (2018)
6.5.3 Business Strategies
6.6 Thermo Fisher Scientific Inc
6.6.1 Business Overview
6.6.2 Financial Overview
Table 55: Thermo Fisher Scientific Revenue and Net Income (2014-2018)
Table 56: Thermo Fisher Scientific Revenue by Segment (2018)
Table 57: Thermo Fisher Scientific Revenue by Region (2018)
6.6.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report